1. Home
  2. EOLS vs FBIZ Comparison

EOLS vs FBIZ Comparison

Compare EOLS & FBIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • FBIZ
  • Stock Information
  • Founded
  • EOLS 2012
  • FBIZ 1909
  • Country
  • EOLS United States
  • FBIZ United States
  • Employees
  • EOLS N/A
  • FBIZ N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • FBIZ Major Banks
  • Sector
  • EOLS Health Care
  • FBIZ Finance
  • Exchange
  • EOLS Nasdaq
  • FBIZ Nasdaq
  • Market Cap
  • EOLS 406.9M
  • FBIZ 390.3M
  • IPO Year
  • EOLS 2018
  • FBIZ N/A
  • Fundamental
  • Price
  • EOLS $6.37
  • FBIZ $50.69
  • Analyst Decision
  • EOLS Strong Buy
  • FBIZ Buy
  • Analyst Count
  • EOLS 4
  • FBIZ 3
  • Target Price
  • EOLS $21.25
  • FBIZ $58.67
  • AVG Volume (30 Days)
  • EOLS 1.0M
  • FBIZ 41.3K
  • Earning Date
  • EOLS 11-05-2025
  • FBIZ 10-30-2025
  • Dividend Yield
  • EOLS N/A
  • FBIZ 2.37%
  • EPS Growth
  • EOLS N/A
  • FBIZ 22.50
  • EPS
  • EOLS N/A
  • FBIZ 5.60
  • Revenue
  • EOLS $277,941,000.00
  • FBIZ $150,952,000.00
  • Revenue This Year
  • EOLS $13.68
  • FBIZ $17.98
  • Revenue Next Year
  • EOLS $27.96
  • FBIZ $8.16
  • P/E Ratio
  • EOLS N/A
  • FBIZ $8.76
  • Revenue Growth
  • EOLS 17.15
  • FBIZ 8.24
  • 52 Week Low
  • EOLS $5.71
  • FBIZ $42.18
  • 52 Week High
  • EOLS $17.82
  • FBIZ $56.46
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 45.10
  • FBIZ 50.05
  • Support Level
  • EOLS $5.92
  • FBIZ $46.07
  • Resistance Level
  • EOLS $6.42
  • FBIZ $50.64
  • Average True Range (ATR)
  • EOLS 0.24
  • FBIZ 1.33
  • MACD
  • EOLS 0.05
  • FBIZ -0.16
  • Stochastic Oscillator
  • EOLS 70.55
  • FBIZ 77.47

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About FBIZ First Business Financial Services Inc.

First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.

Share on Social Networks: